8
Views
2
CrossRef citations to date
0
Altmetric
Symposium: What We Really Know About Pediatric Ophthalmology and Strabismus: The Application of Evidence-Based Medicine

ROP: A Cautionary Tale: What we Know and what we Think we Know

, M.D.
Pages 9-16 | Published online: 22 Dec 2017

References

  • PCryotherapy for Retinopathy of Prematurity Cooperative Group: Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol 1988; 106: 471–479.
  • PCryotherapy for Retinopathy of Prematurity Cooperative Group: Multicenter trial of cryotherapy for retinopathy of prematurity: Three month outcome. Arch Ophthalmol 1990; 108: 195–204.
  • PReynolds JD, Hardy RJ, Kennedy KA, Spencer R, Fielder AR, for the Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group: Lack of efficacy of light reduction in preventing retinopathy of prematurity. N Engl J Med 1998; 338: 1572–1576.
  • PThe STOP-ROP Multicenter Study Group: Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP): A randomized, controlled trial—I: Primary outcomes. Pediatrics 2000; 105: 295–310.
  • PEarly Treatment for Retinopathy of Prematurity Cooperative Group: Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003; 121: 1684–1696.
  • PCommittee for the Classification of Retinopathy of Prematurity: An international classification of retinopathy of prematurity. Arch Ophthalmol 1984; 102: 1130–1134.
  • PInternational Committee for the Classification of the Late Stages of Retinopathy of Prematurity: An international classification of retinopathy of prematurity: II. The classification of retinal detachment. Arch Ophthalmol 1987; 105: 906–912.
  • PAn International Committee for the Classification of Retinopathy of Prematurity. Arch Ophthalmol 2005; 123: 991–999.
  • PRepka MX, Palmer EA, Tung B, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group: Involution of retinopathy of prematurity. Arch Ophthalmol 2000; 118: 645–649.
  • PSection on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology, and American Association of Pediatric Ophthalmology and Strabismus: Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 117: 572–576.
  • PERRATA. Section on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology, and American Association of Pediatric Ophthalmology and Strabismus: Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 118: 1324.
  • Kupfer C, McManus E, Berlage N. History of the National Eye Institute 1968–2000. Bethesda: National Eye Institute; 2009.
  • Ppalmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group: Incidence and early course of retinopathy of prematurity. Ophthalmology 1991; 98: 1628–1640.
  • PEarly Treatment of Retinopathy of Prematurity Cooperative Group: The incidence and course of retinopathy of prematurity: Findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005; 116: 15–23.
  • PReynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer D, Tung B, for the CRYO-ROP and LIGHT-ROP Cooperative Groups: Evidence-based screening criteria for retinopathy of prematurity. Arch Ophthalmol 2002; 120: 1470–1476.
  • Reynolds JD: Malpractice and the quality of care in retinopathy of prematurity (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc 2007; 105: 461–480.
  • Tasman W: Management of retinopathy of prematurity. Ophthalmology 1985; 92: 995–999.
  • Tasman W, Brown GC, Schaffer DB, Quinn G, Naidoff M, Benson WE, Diamond G: Cryotherapy for active retinopathy of prematurity. Ophthalmology 1986; 93: 580–585.
  • Tamai A, Iyota K, Wada H, Ueno H, Noda K, Kishi S, Toyota E, Uchida K: Management of retinopathy of prematurity by photocoagulation or cryocautery. J Ocul Ther Surg 1985; 4: 116–121.
  • Ben-Sira I, Nissenkorn I, Weinberger D, Shohat M, Kremer I, Krikler R, Reisner S: Long-term results of cryotherapy for active stages of retinopathy of prematurity. Ophthalmology 1986; 93: 1423–1428.
  • Terry TL: Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: I. Preliminary report. Am J Ophthalmol 1942; 25: 203–204.
  • Terry TL: Fibroblastic overgrowth of persistent tunica vasculosa lentis in premature infants: II. Report of cases—clinical aspects. Arch Ophthalmol 1943; 29: 36–53.
  • Owens WC, Owens EU: Retrolental fibroplasia in premature infants. Am J Ophthalmol 1949; 32: 1–21.
  • Campbell K: Intensive oxygen therapy as a possible cause of retrolental fibroplasia: A clinical approach. Med J Austral 1951; 2: 48–50.
  • Ashton N, Ward B, Serpell G: Role of oxygen in the genesis of retrolental fibroplasia: A preliminary report. Br J Ophthalmol 1953; 37: 513–520.
  • Ashton N, Ward B, Serpell G: Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasias. Br J Ophthalmol 1954; 38: 397–432.
  • Patz A, Hoeck LE, De La Cruz E: Studies on the effect of high oxygen administration in retrolental fibroplasia: I. Nursery observations. Am J Ophthalmol 1952; 35: 1248–1253.
  • Patz A, Eastham A, Higginbotham D, Kleh T: Oxygen studies in retrolental fibroplasia: II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol 1953; 36: 1511–1522.
  • Kinsey VE: Retrolental fibroplasia: Etiology of retrolental fibroplasia and preliminary report of the cooperative study of retrolental fibroplasia. Trans Am Acad Ophthalmol Otolaryngol 1955; 59: 15–24.
  • Kinsey VE: Retrolental fibroplasia: Cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol 1956; 56: 481–543.
  • Bolton DPG, Gross KW: Further observations on cost of preventing retrolental fibroplasia. Lancet 1974; 1: 445–448.
  • Gaynon MW, Stevenson DK, Sunshine P, Fleisher BE, Landers MB: Supplemental oxygen may decrease progression of prethreshold disease to threshold retinopathy of prematurity. J Perinatol 1997; 17: 434–438.
  • Seiberth V, Linderkamp O, Akkoyun-Vardarli I, Jendritza W, Voegele C, Knorz MC: Oxygen therapy in acute retinopathy of prematurity stage 3. Invest Ophthalmol Vis Sci 1998; 39: S820.
  • Tin W, Milligan SWA, Pennefather P, Hey E: Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child 2001; 84: F106–110.
  • Sun SC: Relation of target SpO2 levels and clinical outcome in ELBW infants on supplemental oxygen. Pediatr Res 2002; 51: Abstract 350.
  • PChow LC, Wright KW, Sola A, the CSMC Oxygen Administration Study Group: Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339–345.
  • Anderson CG, Benitz WE, Madan A: Retinopathy of prematurity and pulse oximetry: A national survey of recent practices. J Perinatol 2004; 24: 164–168.
  • Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM: Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959–967.
  • Silverman WA: A cautionary tale about supplemental oxygen: The albatross of neonatal medicine. Pediatrics 2004; 113: 394–396.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.